The National Academy of Engineering has awarded Leroy Hood the Fritz J. and Dolores H. Russ Prize of $500,000 for his work in automating DNA sequencing. Hood is the president and co-founder of the Institute for Systems Biology in Seattle. He has also helped launch companies such as Amgen and Applied Biosystems.
BioMarker Strategies announced this week that it has appointed Samuel Broder, Mark Velleca, and Paul Beresford to its board of directors.
Broder is a former director of the National Cancer Institute and the former chief medical officer at Celera. Velleca is a senior advisor at Gilead Sciences and the founder of CGI Pharmaceuticals. Beresford is the vice president of business development at Biodesix and the former vice president of translational diagnostics at Ventana Medical Systems.
Hycult Biotech this week named Dino DiCamillo executive director of its newly incorporated US subsidiary.
Previously DiCamillo served as vice president and officer of Advanced Research Technologies, president of Alfa Wassermann Proteomics, vice president of environmental diagnostics at Invitrogen, and president of Dynal Biotech.